These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15196591)

  • 21. A porcine model of complement-mediated infusion reactions to drug carrier nanosystems and other medicines.
    Szebeni J; Bedőcs P; Csukás D; Rosivall L; Bünger R; Urbanics R
    Adv Drug Deliv Rev; 2012 Dec; 64(15):1706-16. PubMed ID: 22820530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complement activation by PEGylated liposomes containing prednisolone.
    van den Hoven JM; Nemes R; Metselaar JM; Nuijen B; Beijnen JH; Storm G; Szebeni J
    Eur J Pharm Sci; 2013 May; 49(2):265-71. PubMed ID: 23528740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.
    Fearon DT; Daha MR; Strom TB; Weiler JM; Carpenter CB; Austen KF
    Transplant Proc; 1977 Mar; 9(1):729-39. PubMed ID: 325806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
    Mayes JT; Schreiber RD; Cooper NR
    J Clin Invest; 1984 Jan; 73(1):160-70. PubMed ID: 6418767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention.
    Szebeni J; Muggia F; Gabizon A; Barenholz Y
    Adv Drug Deliv Rev; 2011 Sep; 63(12):1020-30. PubMed ID: 21787819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct polymer architecture mediates switching of complement activation pathways at the nanosphere-serum interface: implications for stealth nanoparticle engineering.
    Hamad I; Al-Hanbali O; Hunter AC; Rutt KJ; Andresen TL; Moghimi SM
    ACS Nano; 2010 Nov; 4(11):6629-38. PubMed ID: 21028845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxidation of low-density lipoprotein cholesterol following administration of poloxamer 407 to mice results from an indirect effect.
    Johnston TP; Zhou X
    J Cardiovasc Pharmacol; 2007 Apr; 49(4):246-52. PubMed ID: 17438410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of the alternative pathway of complement during the acute phase of typical haemolytic uraemic syndrome.
    Ferraris JR; Ferraris V; Acquier AB; Sorroche PB; Saez MS; Ginaca A; Mendez CF
    Clin Exp Immunol; 2015 Jul; 181(1):118-25. PubMed ID: 25677399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The terminal complement complex (sC5b-9) is not specifically associated with the development of the adult respiratory distress syndrome.
    Parsons PE; Giclas PC
    Am Rev Respir Dis; 1990 Jan; 141(1):98-103. PubMed ID: 2297192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of complement inhibition and heparin coating on artificial surface-induced leukocyte and platelet activation.
    Lappegård KT; Fung M; Bergseth G; Riesenfeld J; Lambris JD; Videm V; Mollnes TE
    Ann Thorac Surg; 2004 Mar; 77(3):932-41. PubMed ID: 14992902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complement activation during CAPD.
    Young GA; Kendall S; Brownjohn AM
    Nephrol Dial Transplant; 1993; 8(12):1372-5. PubMed ID: 8159307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complement Activation-Related Pseudo-Allergy: A Fresh Look at Hypersensitivity Reactions to Intravenous Iron.
    Macdougall IC; Vernon K
    Am J Nephrol; 2017; 45(1):60-62. PubMed ID: 27894115
    [No Abstract]   [Full Text] [Related]  

  • 33. The influence of repeated administration of poloxamer 407 on serum lipoproteins and protease activity in mouse liver and heart.
    Korolenko TA; Tuzikov FV; Johnston TP; Tuzikova NA; Kisarova YA; Zhanaeva SY; Alexeenko TV; Zhukova NA; Brak IV; Spiridonov VK; Filjushina EE; Cherkanova MS; Monoszon AA
    Can J Physiol Pharmacol; 2012 Nov; 90(11):1456-68. PubMed ID: 23181274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of alternative complement pathway dysregulation by a phosphorothioate oligonucleotide in monkey and human serum.
    Henry SP; Jagels MA; Hugli TE; Manalili S; Geary RS; Giclas PC; Levin AA
    Nucleic Acid Ther; 2014 Oct; 24(5):326-35. PubMed ID: 25093529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: comparison of the porcine and rat responses.
    Dézsi L; Fülöp T; Mészáros T; Szénási G; Urbanics R; Vázsonyi C; Őrfi E; Rosivall L; Nemes R; Kok RJ; Metselaar JM; Storm G; Szebeni J
    J Control Release; 2014 Dec; 195():2-10. PubMed ID: 25148822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic Variants and Systemic Complement Activation Levels Are Associated With Serum Lipoprotein Levels in Age-Related Macular Degeneration.
    Paun CC; Ersoy L; Schick T; Groenewoud JM; Lechanteur YT; Fauser S; Hoyng CB; de Jong EK; den Hollander AI
    Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):7766-73. PubMed ID: 26641553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activation of human complement by nitrogen bubbles.
    Shastri KA; Logue GL; Lundgren CE
    Undersea Biomed Res; 1991 May; 18(3):157-65. PubMed ID: 1853466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A systematic analysis of the complement pathways in patients with neuromyelitis optica indicates alteration but no activation during remission.
    Veszeli N; Füst G; Csuka D; Trauninger A; Bors L; Rozsa C; Nagy Z; Jobbágy Z; Eizler K; Prohászka Z; Varga L; Illes Z
    Mol Immunol; 2014 Feb; 57(2):200-9. PubMed ID: 24172223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Possible protective role for C-reactive protein in atherogenesis: complement activation by modified lipoproteins halts before detrimental terminal sequence.
    Bhakdi S; Torzewski M; Paprotka K; Schmitt S; Barsoom H; Suriyaphol P; Han SR; Lackner KJ; Husmann M
    Circulation; 2004 Apr; 109(15):1870-6. PubMed ID: 15037531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complement activation in platelet concentrates is surface-dependent and modulated by the platelets.
    Gyongyossy-Issa MI; McLeod E; Devine DV
    J Lab Clin Med; 1994 Jun; 123(6):859-68. PubMed ID: 8201264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.